Eli Lilly and Company
Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide. It offers endocrinology products for diabetes; osteoporosis in postmenopausal women and men; and human growth hormone deficiency and paediatric growth conditions. The company also provides neuroscience products for treating depressive disorder, diabetic peripheral neuropathic pain, anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; migraine and episodic cluster headache; attention-deficit hyperactivity disorder; and schizophrenia. In addition, it offers immunology products for the treatment of rheumatoid arthritis, plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis; oncology products to treat non-small cell lung, colorectal, head and neck, pancreatic, metastatic breast, ovarian, bladder, and metastatic gastric cancers, as well as malignant pleural mesothelioma; and products to treat erectile dysfunction and benign prostatic hyperplasia. Eli Lilly and Company primarily has collaborations with Incyte Corporation; Pfizer Inc.; Dicerna Pharmaceuticals, Inc.; AC Immune SA; Centrexion Therapeutics Corporation; ImmuNext, Inc.; and Avidity Biosciences, Inc., as well as AbCellera Biologics Inc. The company was founded in 1876 and is headquartered in Indianapolis, Indiana. Show More...
-
Website http://www.lilly.com
-
Sector Healthcare
-
Industry Drug Manufacturers-General
-
Last Quote 649.10 EUR
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share USD 4.58 3.9 3.66 4.32 2.23 2.26 2.58 -0.19 3.13 8.89 6.18 Dividends USD 1.96 1.96 2.45 1.96 1.96 2.0 2.04 2.08 2.25 2.58 2.67 Payout Ratio % * 33.7 46.9 66.4 44.8 78.4 89.6 66.1 122.9 469.7 55.5 44.6 Shares Mil 1.106 1.114 1.117 1.085 1.074 1.066 1.062 1.052 1.034 936.0 918.0 Book Value Per Share * EUR 6.72 10.04 10.58 11.0 13.09 12.61 13.4 11.34 10.82 3.16 2.91 Free Cash Flow Per Share * EUR 3.69 4.05 3.22 3.06 2.36 1.27 2.1 2.96 2.47 2.48 Return on Assets % 17.34 13.45 12.01 13.45 6.6 6.62 7.36 -0.49 7.27 20.0 13.99 Financial Leverage (Average) 2.49 2.49 2.33 2.0 2.42 2.44 2.77 3.88 4.47 15.07 13.35 Return on Equity % 46.2 33.49 28.89 28.92 14.49 16.09 19.16 -1.59 30.18 133.78 199.07 Return on Invested Capital % 29.12 22.24 20.3 21.87 10.43 10.75 11.95 -0.68 13.91 41.94 29.74 Interest Coverage 36.18 29.76 31.42 37.79 21.16 18.31 19.22 10.77 14.95 14.14 16.28 Current Ratio 2.09 1.6 1.55 1.47 1.09 1.53 1.37 1.32 1.73 1.16 1.11 Quick Ratio 1.53 1.25 1.14 1.06 0.77 1.04 0.98 0.91 1.2 0.68 0.64 Debt/Equity 0.55 0.4 0.37 0.24 0.35 0.55 0.6 0.86 1.18 5.49 4.54